NCT05869721

Brief Summary

Upper limb complications and sleep disturbances are prevalent, persistent, and serious health problems in women with breast cancer. However, these problems are underrecognized in clinical practice and thus have substantial adverse impacts on the health and quality of life of women with breast cancer. As yoga practices have been shown to improve physical and psychological health in people with cancer, such practices may also alleviate upper limb complications and sleep disturbances in women with breast cancer. However, there are few evidence-based guidelines or protocols to support the integration of yoga therapy into clinical practice for managing the health conditions of women with breast cancer. Therefore, this study aims to investigate the effects of yoga therapy on improving the upper limb functions, sleep quality, and quality of life in women with breast cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 3, 2023

Completed
1 day until next milestone

Study Start

First participant enrolled

May 4, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

May 22, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2024

Completed
Last Updated

October 3, 2024

Status Verified

October 1, 2024

Enrollment Period

1.2 years

First QC Date

May 3, 2023

Last Update Submit

October 1, 2024

Conditions

Outcome Measures

Primary Outcomes (8)

  • Upper limb functional status, score range 0-100%, higher score means more severe disability

    Will be assessed using the short form of the Chinese (Hong Kong) version of the Disabilities of Arm-Shoulder-Hand Questionnaire (quickDASH-HKPWH)

    T1: baseline (before the study begins).

  • Change from baseline Upper limb functional status at 4 weeks

    Will be assessed using the short form of the Chinese (Hong Kong) version of the Disabilities of Arm-Shoulder-Hand Questionnaire (quickDASH-HKPWH), score range 0-100%, higher score means more severe disability

    T2: mid-intervention (week 4)

  • Change from baseline Upper limb functional status at 8 weeks

    Will be assessed using the short form of the Chinese (Hong Kong) version of the Disabilities of Arm-Shoulder-Hand Questionnaire (quickDASH-HKPWH), score range 0-100%, higher score means more severe disability

    T3: immediately post-intervention (week 8)

  • Change from baseline Upper limb functional status at 12 weeks

    Will be assessed using the short form of the Chinese (Hong Kong) version of the Disabilities of Arm-Shoulder-Hand Questionnaire (quickDASH-HKPWH), score range 0-100%, higher score means more severe disability

    T4: 1 month follow up (week 12)

  • Sleep quality

    Will be assessed by the Chinese (for Hong Kong) version of the Pittsburgh Sleep Quality Index questionnaire, score range 0-21, higher score means poorer sleep

    T1: baseline (before the study begins)

  • Change from baseline Sleep quality at 4 weeks

    Will be assessed by the Chinese (for Hong Kong) version of the Pittsburgh Sleep Quality Index questionnaire, score range 0-21, higher score means poorer sleep

    T2: mid-intervention (week 4)

  • Change from baseline Sleep quality at 8 weeks

    Will be assessed by the Chinese (for Hong Kong) version of the Pittsburgh Sleep Quality Index questionnaire, score range 0-21, higher score means poorer sleep

    T3: immediately post intervention (week 8)

  • Change from baseline Sleep quality at 12 weeks

    Will be assessed by the Chinese (for Hong Kong) version of the Pittsburgh Sleep Quality Index questionnaire, score range 0-21, higher score means poorer sleep

    T4: 1 month follow up (week 12)

Secondary Outcomes (24)

  • Upper limb muscle strength

    T1: baseline (before the study begins)

  • Change from baseline Upper limb muscle strength at 4 weeks

    T2: mid-intervention (week 4)

  • Change from baseline Upper limb muscle strength at 8 weeks

    T3: immediately post intervention (week 8)

  • Change from baseline Upper limb muscle strength at 12 weeks

    T4: 1 month follow up (week 12)

  • Shoulder mobility

    T1: baseline (before the study begins)

  • +19 more secondary outcomes

Study Arms (2)

Yoga group

EXPERIMENTAL

Participants will receive yoga programme over a period of eight weeks

Other: Yoga

Control group

NO INTERVENTION

The participants in the control group will receive usual care, and complete all assessments on the same timeline as the intervention group. They will be offered yoga programme at the completion of the final measurement.

Interventions

YogaOTHER

The yoga forms are designed from the modified traditional Hatha yoga style consisting of pranayama, asana, meditation with additional relaxation elements. The selected postures will engage core and upper limb muscle and which proposed to strengthen the whole body, increase flexibility of shoulder and limbs, particularly, improve upper limb mobility and functions; also, the progression of the yoga therapy is targeted to reach the variations of postures. The combined relaxation elements reinforced to achieve restoration of the body so as to improve sleep.

Yoga group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen with breast cancer (based on self-representation of gender identity)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged ≥18
  • Female
  • Normal cognitive function
  • Diagnosed with primary breast cancer of stage I-III
  • Completed cancer-related treatments (including surgery, radiotherapy, and/or chemotherapy) at least 4 weeks before enrollment except conventional medical care (e.g., hormonal therapy)

You may not qualify if:

  • Diagnosed with distant metastasis in non-breast body part
  • Diagnosed with significant diseases, such as cardiovascular, respiratory, neurological, musculoskeletal (except upper-extremity problems secondary to breast cancer), endocrine, metabolic, and psychological disorders
  • Being pregnant
  • Prior experiences of practicing yoga

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

A university-affiliated rehabilitation laboratory

Hung Hom, Kowloon, Hong Kong

Location

The Hong Kong Polytechnic University

Hong Kong, Hong Kong

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Interventions

Yoga

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual TherapiesExercise Movement TechniquesPhysical Therapy Modalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
After the baseline assessment, all eligible participants will be allocated randomly in a 1:1 ratio to either (1) experimental group which received yoga programme over a period of eight weeks, or (2) wait-list control group. The research assistant, who is responsible for allocation, is independent from the data collection and analysis, and the intervention. The participants will be reminded not to disclose information related to group allocation to the assessors to prevent possible bias during measurement. All assessments will be performed by an assessor who is blinded to the group allocation and not involved in the delivery of the intervention.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This pilot randomized controlled trial will conduct at a university-affiliated rehabilitation laboratory staring from May 2023 in Hong Kong.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 3, 2023

First Posted

May 22, 2023

Study Start

May 4, 2023

Primary Completion

July 30, 2024

Study Completion

July 30, 2024

Last Updated

October 3, 2024

Record last verified: 2024-10

Locations